QT Medical Participates in APSC × TSOC 2026, Highlighting the Clinical Value of AI ECG and Smart 12-Lead ECG Solutions

Event

QT Medical Participates in APSC × TSOC 2026, Highlighting AI ECG and Smart 12-Lead ECG Solutions

TAIPEI – May 19, 2026

QT Medical Participates in APSC × TSOC 2026, Highlighting the Clinical Value of AI ECG and Smart 12-Lead ECG Solutions

QT Medical was honored to participate in APSC × TSOC 2026, held in Taipei, Taiwan. The congress brought together leading cardiologists, healthcare professionals, researchers, and industry partners from across the Asia-Pacific region to exchange insights on cardiovascular care, clinical innovation, and the future of digital health.

During the event, QT Medical showcased its smart 12-lead ECG solutions and was pleased to see its technology featured in the AI Zone and related scientific presentations and demonstrations. These sessions highlighted the real-world clinical applications and research potential of AI ECG, reflecting the growing importance of advanced ECG technology in supporting more efficient cardiac assessment and clinical decision-making.

QT Medical would like to extend its sincere appreciation to Tri-Service General Hospital and China Medical University Hospital for sharing their valuable experience and clinical insights on AI ECG applications. We are honored that QT Medical’s technology has been applied in these important clinical research initiatives, and we deeply appreciate the opportunity to support meaningful advancements in cardiovascular care.

At the exhibition booth, QT Medical presented its smart 12-lead ECG portfolio, including PCA 500, QHeart® Sensor, QHeart® Sensor F, and a preview of the upcoming QCA Pro model. Through lightweight device design, simplified electrode placement, standard 12-lead ECG acquisition, cloud-based management, and advanced analysis capabilities, QT Medical aims to help healthcare teams build more efficient and flexible ECG workflows across hospitals, clinics, mobile healthcare, and remote care settings.

We also sincerely thank all physicians, healthcare professionals, and industry partners who visited the QT Medical booth. Your recognition, feedback, and valuable discussions continue to inspire us as we advance smarter ECG solutions and expand their clinical applications.

QT Medical will continue to work closely with healthcare teams and partners to promote more efficient, flexible, and clinically valuable cardiovascular care solutions powered by smart 12-lead ECG technology.

We look forward to seeing you again very soon.